NEOGINE 1 GM INJECTION

NEOGINE 1 GM INJECTION contains Ceftriaxone Sodium as its active ingredient. Ceftriaxone is a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections. It works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria and subsequent resolution of the infection.

Uses:

NEOGINE 1 GM INJECTION is prescribed for the treatment of various bacterial infections caused by susceptible organisms. It is commonly used for:

• Lower respiratory tract infections (such as pneumonia).
• Urinary tract infections (including cystitis and pyelonephritis).
• Skin and soft tissue infections (such as cellulitis).
• Intra-abdominal infections (including peritonitis).
• Bacterial meningitis.
• Gonorrhea.
• Lyme disease.
• Septicemia.

Administration:

NEOGINE 1 GM INJECTION is administered by intramuscular or intravenous injection, as directed by a healthcare professional. The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient’s age, weight, and renal function. It is essential to follow the prescribed dosage regimen and complete the full course of treatment to ensure the infection is eradicated and to prevent the development of antibiotic resistance.

Side Effects:

Common side effects of NEOGINE 1 GM INJECTION may include gastrointestinal disturbances (such as nausea, vomiting, diarrhea), headache, dizziness, rash, and injection site reactions (such as pain, redness, or swelling). Serious side effects such as allergic reactions (including anaphylaxis), severe diarrhea (including Clostridium difficile-associated diarrhea), and liver dysfunction may occur rarely. If any adverse effects are experienced, medical attention should be sought promptly.

Precautions:

Before using NEOGINE 1 GM INJECTION, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. Caution should be exercised in patients with a history of hypersensitivity reactions to cephalosporins or penicillins. Additionally, patients with renal impairment should be monitored closely, as dosage adjustments may be necessary.

Contraindications:

NEOGINE 1 GM INJECTION is contraindicated in patients with known hypersensitivity to cephalosporin antibiotics. It should not be used in individuals with a history of severe allergic reactions to beta-lactam antibiotics (including penicillins). Caution should be exercised in patients with a history of gastrointestinal disease, particularly colitis, as antibiotic-associated colitis may occur.

Conclusion:

NEOGINE 1 GM INJECTION, containing Ceftriaxone Sodium, is an effective antibiotic used to treat a wide range of bacterial infections. It is important to use this medication judiciously, following the guidance of a healthcare professional, to ensure optimal therapeutic outcomes and minimize the risk of adverse effects.